Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Erythropoietin Treatment Leads to Reduced Blood Glucose Levels and Body Mass: Insights From Murine Models.

Odelia Katz, PhD, Matthew Stuible, Nataliya Golishevski, MD, Lilach Lifshitz, MD/PhD-student, Michel Tremblay, PhD, FRSC, Max Gassman, PhD, Howard S Oster, MD, PhD, Moshe Mittelman, MD, Drorit Neumann, PhD

Blood (2009) 114 (22): 4557.

https://doi.org/10.1182/blood.V114.22.4557.4557

Published: 2009

Journal Articles

Erythropoietin Treatment Is Associated with Augmented Immune Response to the Influenza Vaccine in Hematologic Patients.

Howard S Oster, MD, PhD, Sara Prutchi-Sagiv, PhD, Ora Halutz, Nataliya Golishevski, MD, Moshe Binyamin, MD, Ruth Orkin, MD, Michael Hoffman, MD, Drorit Neumann, PhD, Moshe Mittelman, MD

Blood (2009) 114 (22): 1637.

https://doi.org/10.1182/blood.V114.22.1637.1637

Published: 2009

Journal Articles

T-Cell Abnormalities in Patients with Myelodysplastic Syndromes: Improved Immunological Functions in Patients Treated with Recombinant Erythropoietin.

Sara Prutchi-Sagiv, MSc, Nataliya Golishevski, MD, Odelia Katz, MSc, Howard S. Oster, MD PhD, Elizabeth Naparstek, MD, Michael Hoffman, MD, Drorit Neumann, PhD, Moshe Mittelman, MD

Blood (2006) 108 (11): 2675.

https://doi.org/10.1182/blood.V108.11.2675.2675

Published: 2006

Journal Articles

Erythropoietin Treatment in Advanced Multiple Myeloma Is Associated with Improved Immunological Functions: Could It Be Beneficial in Early Disease?.

Sara Prutchi-Sagiv, MSc, Nataliya Golishevski, MD, Howard S. Oster, MD, PhD, Odelia Katz, MSc, Naparstek Elizabeth, MD, Amos Cohen, MD, Michael Hoffman, MD, Drorit Neumann, PhD, Moshe Mittelman, MD

Blood (2006) 108 (11): 3499.

https://doi.org/10.1182/blood.V108.11.3499.3499

Published: 2006

Journal Articles

Improved Glycemic Control in Diabetic Patients Treated with Recombinant Human Erythropoietin.

Odelia Katz, MSc, Nataliya Golishevski, MD, Howard S. Oster, MD, PhD, Lilach Lifshitz, BSc, Sari Prutchi-Sagiv, MSc, Michael Hoffman, MD, Moshe Mittelman, MD, Drorit Neumann, PhD

Blood (2006) 108 (11): 4228.

https://doi.org/10.1182/blood.V108.11.4228.4228

Published: 2006

NARROW

Erythropoietin Treatment Leads to Reduced Blood Glucose Levels and Body Mass: Insights From Murine Models.

Erythropoietin Treatment Is Associated with Augmented Immune Response to the Influenza Vaccine in Hematologic Patients.

T-Cell Abnormalities in Patients with Myelodysplastic Syndromes: Improved Immunological Functions in Patients Treated with Recombinant Erythropoietin.

Erythropoietin Treatment in Advanced Multiple Myeloma Is Associated with Improved Immunological Functions: Could It Be Beneficial in Early Disease?.

Improved Glycemic Control in Diabetic Patients Treated with Recombinant Human Erythropoietin.

Email alerts

ASH Publications

American Society of Hematology

Erythropoietin Treatment Leads to Reduced Blood Glucose Levels and Body Mass: Insights From Murine Models.

Erythropoietin Treatment Is Associated with Augmented Immune Response to the Influenza Vaccine in Hematologic Patients.

T-Cell Abnormalities in Patients with Myelodysplastic Syndromes: Improved Immunological Functions in Patients Treated with Recombinant Erythropoietin.

Erythropoietin Treatment in Advanced Multiple Myeloma Is Associated with Improved Immunological Functions: Could It Be Beneficial in Early Disease?.

Improved Glycemic Control in Diabetic Patients Treated with Recombinant Human Erythropoietin.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only